ForumIAS LATEST
- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
News:India and the U.S have decided to work together on vaccine research and testing for COVID-19 under the Indo-U.S. Vaccine Action Program(VAP).
Facts:
- The Indo-US Vaccine Action Programme(VAP) is a bilateral programme established in 1987.
- Aim: To develop and evolve joint R&D projects towards development of safe and efficacious vaccines against some of the major communicable diseases that presently take a large toll in India & USA.
- Nodal Agencies: U.S. National Institutes of Health, Indian Department of Biotechnology(DBT) and Indian Council of Medical Research(ICMR) along with other partners.
Additional Facts:
Global Vaccine Action Plan(GVAP):
- It is a framework adopted at the 65th World Health Assembly in 2012 to achieve the vision of the Decade of Vaccines 2011-2020(DoV).
- Aim: To prevent millions of deaths by 2020 through more equitable access to existing vaccines for people in all communities.
